「Antibody」の共起表現一覧(1語右で並び替え)
該当件数 : 341件
Gomiliximab is a monoclonal | antibody acting as an immunosuppressive drug for the t |
Nerelimomab is a mouse monoclonal | antibody acting as a TNF inhibitor. |
In the gastrointestinal tract, the | antibody acts as a cholesterol absorption inhibitor. |
It is the primary | antibody against A and B antigens on red blood cells. |
Urtoxazumab is a humanized monoclonal | antibody against diarrhoea caused by Escherichia coli, |
ns became immunoreactive to 1C2 (a monoclonal | antibody against expanded polyglutamine stretches) inc |
ezumab (INN, codenamed RN624) is a monoclonal | antibody against nerve growth factor. |
29) is an aglycosylated, humanized monoclonal | antibody against interleukin-6. |
s ETR2-ST01) is an agonistic human monoclonal | antibody against TRAIL-R2 (DR5, APO-2) used in the tre |
Clenoliximab (INN) is a monoclonal | antibody against CD4. |
Felvizumab is a humanized monoclonal | antibody against respiratory syncytial virus. |
Vitaxin is a humanized monoclonal | antibody against the vascular integrin avb3. |
ed of an intact murine (mouse) IgM monoclonal | antibody against human CD15, labeled with technetium-9 |
An | antibody against the N-terminus of the birtoxin protei |
zumab is a humanized Fc-engineered monoclonal | antibody also known as MGA031 and hOKT3γ1(Ala-Ala). |
ab (also known as B-E8) is a mouse monoclonal | antibody and an immunosuppressive drug. |
n of mouse anti-MBP (maltose binding protein) | antibody and incubation. |
he diversity of these molecules, allowing the | antibody and the T cell receptor to recognize a vast r |
lizumab (IDEC 131) was a humanized monoclonal | antibody and an immunosuppressive drug. |
cing glands) or Edema, M-protein (an abnormal | antibody) and Skin abnormalities (including hyperpigme |
nation of bivatuzumab, a humanized monoclonal | antibody, and mertansine, a cytotoxic agent. |
Pneumonia in a Cotton Rat Model Using Topical | Antibody and Glucocorticosteroid". |
Lerdelimumab (CAT-152) is a human monoclonal | antibody and an immunosuppressive drug developed to re |
CMRF35H is recognized by the same | antibody and is distinct from CMRF35 (Green et al., 19 |
Faralimomab is a mouse monoclonal | antibody and an immunomodulator. |
osed USAN) is a chimeric/humanized monoclonal | antibody and an immunosuppressive drug. |
hen detected by another fluorochrome-labelled | antibody, and is subsequently extracted using a proces |
Fresolimumab is a human monoclonal | antibody and an immunomodulator, developed by Genzyme. |
Lebrikizumab is a humanized monoclonal | antibody and an immunosuppresive drug for the treatmen |
An | antibody, anti-streptolysin O, can be detected in an a |
previous work has proven that this polyclonal | antibody approach is an effective strategy for antiven |
tories) is a fully human TNF-alpha monoclonal | antibody approved for the treatment of rheumatoid arth |
ChIP material bound by the | antibody are used to construct the ChIA-PET. |
d as the combined light and heavy chain of an | antibody arm. |
distinguish the two viruses using monoclontal | antibody based reagents. |
age-ligand technology, AMS is superior to the | antibody based immunomagnetic separation (IMS) on sort |
The commander of the | antibody battalion is an antibody character named Metr |
Afutuzumab is a monoclonal | antibody being developed by Hoffmann-La Roche Inc. for |
Solanezumab (proposed INN) is a monoclonal | antibody being investigated as a neuroprotector for pa |
s SGN-40 or huS2C6) is a humanized monoclonal | antibody being developed for the treatment of CD40-pos |
Rontalizumab is a humanized monoclonal | antibody being developed by Genentech. |
Lucatumumab is a human monoclonal | antibody being investigated for the treatment of vario |
Talizumab (TNX-901) is a humanized monoclonal | antibody being developed by Tanox in Houston, Texas. |
Like the monoclonal | antibody belimumab, atacicept blocks the binding of BL |
y also be potentially deposited without prior | antibody binding. |
It helps to prevent non-specific | antibody binding. |
The | antibody binds to GPNMB on the cancer cells, the ADC i |
In circulation, this | antibody binds selectively to the small, dense, oxidiz |
An anti-IgE | antibody binds IgE and prevents it from initiating an |
The anti-TNF monoclonal | antibody biologics, Infliximab and adalimumab, and the |
the machine to detect the difference between | antibody bound, and unbound fluorescein. |
the drug consists of the chimeric monoclonal | antibody brentuximab (which targets CD30) and three to |
A primary | antibody can be very useful for the detection of bioma |
the anti-IgE program and developed prototype | antibody candidates in 1987. |
the efficacy of treatment with the monoclonal | antibody cetuximab can be assessed by the expression p |
types of bispecific antibodies: trifunctional | antibody, chemically linked Fab and bi-specific T-cell |
as cytokine production by T lymphocytes, and | antibody class switching by B cells, are division depe |
cells; subsequent studies have employed this | antibody conjugated with the potent cytotoxic compound |
For example, an | antibody conjugated to HRP may be used to detect a sma |
are classical Ig-like domains resembling the | antibody constant domain. |
iodine (131I) tositumomab, which is the same | antibody covalently bound to the radionuclide iodine-1 |
It is a IgG2a anti-CD20 monoclonal | antibody derived from immortalized mouse cells. |
s been presented as a possible alternative to | antibody design for applications requiring high-affini |
5 was initially detected using the monoclonal | antibody designated OC125. |
Panobacumab (proposed INN) is a monoclonal | antibody designed as an antibacterial against Pseudomo |
Taplitumomab paptox is a mouse monoclonal | antibody designed for the treatment of cancer. |
Tenatumomab is a monoclonal | antibody designed for the treatment of cancer. |
me Rexomun) is a rat-murine hybrid monoclonal | antibody designed to treat some types of cancer. |
cle tissue, stamulumab is a recombinant human | antibody designed to bind to and inhibit the activity |
Minretumomab is a mouse monoclonal | antibody designed for the treatment of cancer. |
Galiximab is a monoclonal | antibody designed for the treatment of B-cell lymphoma |
for amplification to 72 degrees, the specific | antibody detaches from Taq-polymerase and the amplific |
name of an anti-HER2/neu targeting monoclonal | antibody developed by MacroGenics. |
Vepalimomab is a mouse monoclonal | antibody developed for the treatment of inflammations. |
dministration (FDA) approved human monoclonal | antibody developed by Bristol-Myers Squibb, and works |
Inolimomab is a mouse monoclonal | antibody developed as an immunosuppressive drug agains |
Certolizumab pegol is a monoclonal | antibody directed against tumor necrosis factor alpha. |
Libivirumab is a human monoclonal | antibody directed against the hepatitis B virus. |
A Fc-domain optimized IgG monoclonal | antibody directed against the human epidermal growth f |
The | antibody does not bind the good forms of cholesterol s |
GMP manufacturing of recombinant proteins and | antibody drug conjugates (e.g. |
ministration approval of the first monoclonal | antibody drug, Muronomab-CD3 (also known as Orthoclone |
Nowadays genetic drugs and | antibody drugs are replacing the chemical drugs which |
Cytolysin refers to the substance or | antibody elaborated by microorganisms, plants or anima |
and inspired the development of the field of | antibody engineering. |
Omalizumab is a glycosylated monoclonal | antibody expressed by mammalian cells. |
fragment of IMMU-4, a murine IgG1 monoclonal | antibody extracted from the ascites of mice. |
Citatuzumab bogatox (VB6-845) is a monoclonal | antibody Fab fragment fused with bouganin, an ribosome |
23 is known to have role of transportation in | antibody feedback regulation. |
ted as a guide and inspiration to many in the | antibody field as well as devoting himself to assistin |
Tigatuzumab (CS-1008) is a monoclonal | antibody for the treatment of cancer. |
ormerly EMD 72000) was a humanized monoclonal | antibody for the treatment of cancer. |
Pascolizumab is a humanized monoclonal | antibody for the treatment of asthma. |
Keliximab is a monoclonal | antibody for the treatment of severe chronic asthma. |
C49 is an iodine-125 radiolabelled monoclonal | antibody for the detection of tumours. |
Gantenerumab is a monoclonal | antibody for the treatment of Alzheimer's disease. |
Lemalesomab is a mouse monoclonal | antibody for the diagnosis of inflammatory lesions. |
Sevirumab (MSL-109) is a human monoclonal | antibody for the treatment of infections with cytomega |
Pagibaximab is a chimeric monoclonal | antibody for the prevention of staphylococcal sepsis i |
name CEA-CIDE) is a humanized IgG1 monoclonal | antibody for the treatment of colorectal cancer. |
s end, several clever ways of trimerizing the | antibody for in vitro research have been employed. |
brand name Aurexis) is a humanized monoclonal | antibody for the treatment of severe infections with S |
Foravirumab is a monoclonal | antibody for the prophylaxis of rabies. |
99mTc) pintumomab (INN) is a mouse monoclonal | antibody for the imaging of adenocarcinoma. |
Tuvirumab is a human monoclonal | antibody for the treatment of patients with chronic he |
Anatumomab mafenatox is a mouse monoclonal | antibody for the treatment non-small cell lung cancer. |
See also Anti-citrullinated protein | antibody for its use in diagnosis of rheumatoid arthri |
zogamicin (CMC-544) is a humanized monoclonal | antibody for the treatment of cancers. |
e I clinical trial of CGP-51901, the chimeric | antibody form of the humanized anti-IgE antibody, TNX- |
the enzyme-linked immunosorbent assay (ELISA) | antibody format, except that the encapsulated cells re |
Antibody formation to Factor VIII can also be a major | |
cells form the first antibodies, and specific | antibody formation gets started in the process. |
and has a polysaccharide capsule that induces | antibody formation; the different types are classified |
ess proteins such as zinc finger proteins and | antibody fragments on phage pili for the purpose of ph |
Anti-digoxin | antibody fragments, the specific treatment for digoxin |
cANCA (cytoplasmic subtype) class, a type of | antibody frequently found in the disease Wegener's gra |
A humanized anti-IgE | antibody from Genentech, omalizumab, with identical bi |
The drug is a chimeric | antibody from Macaca irus and Homo sapiens. |
Anti-TGF-beta monoclonal | antibody GC1008 is a monoclonal antibody being studied |
produced in plants by transforming them with | antibody genes from animals. |
The fully-human monoclonal | antibody glembatumumab (CR011) is linked to monomethyl |
first-generation BsMAb, called trifunctional | antibody, has been developed. |
Immunology: An | antibody has a fluorescent chemical group attached, an |
ological systems as well it is argued that an | antibody in the human body can generate trioxidane as |
research team first isolated this monoclonal | antibody in 1981. |
s a type of immunoglobulin which is the major | antibody in bird, reptile, and lungfish blood. |
he translation of the optimised single-domain | antibody in E. coli, Saccharomyces cerevisiae or other |
gingivalis one finds high levels of specific | antibody in the serum. |
IgM is by far the physically largest | antibody in the human circulatory system. |
t model of breast cancer, a small-molecule or | antibody inhibitors of LOX abolished metastasis. |
(trade name Antova) is a humanized monoclonal | antibody intended for the treatment of rheumatic disea |
(also known as ABX-CBL) is a mouse monoclonal | antibody intended for use as an immunosuppressive biol |
Reslizumab is a humanized monoclonal | antibody intended for the treatment of eosinophil-medi |
Sibrotuzumab is a humanized monoclonal | antibody intended for the treatment of cancer. |
unctional mutant of this protein with reduced | antibody interaction. |
Mitumomab (BEC-2) is a mouse monoclonal | antibody investigated for the treatment of small cell |
The tertiary structure of an | antibody is important to analyze and design new antibo |
Antibody is a 2002 science fiction thriller directed b | |
A single-domain | antibody is a peptide chain of about 110 amino acids l |
Radiolabeled anti-human IgE | antibody is added where it binds to those IgE antibodi |
At an equivalent dose a trifunctional | antibody is more potent (more than 1,000-fold) in elim |
An antimicrosomal | antibody is an antibody directed against microsomes. |
A secondary | antibody is an antibody that binds to primary antibodi |
The | antibody is linked to the A chain of the ricin protein |
lyl Lewis A antigen, detected with the CA19-9 | antibody, is highly correlated advanced epithelial can |
ntibody (a portmanteau derived from Plant and | antibody) is an antibody produced by genetically modif |
biology, an intrabody (from intracellular and | antibody) is an antibody that works within the cell to |
An anti-CEA | antibody is an antibody against the carcinoembryonic a |
as identified by reactivity with a monoclonal | antibody, is present on monocytes, neutrophils, and so |
IgE | antibody is the receptor responsible for allergic reac |
30 nm away from the site to which the primary | antibody is bound (when using a primary and secondary |
romote effective primary immune responses and | antibody isotype switch and to establish high-affinity |
I, is the "low-affinity" receptor for IgE, an | antibody isotype involved in allergy and resistance to |
interaction, the B cell can undergo division, | antibody isotype switching, and differentiation to pla |
the trade name OvaRex) is a mouse monoclonal | antibody it binds to the antigen CA125, a carbohydrate |
The | antibody itself, taplitumomab, is linked to the protei |
es outside of the antigen-binding site on the | antibody itself. |
(also known as M200) is a chimeric monoclonal | antibody jointly developed by PDL BioPharma and Biogen |
he established the use of bacteriophages and | antibody labeling for studying DNA. |
(trade name Scintimun) is a mouse monoclonal | antibody labelled with the radioactive isotope technet |
b (trade name Myoscint) is a mouse monoclonal | antibody labelled with the radioisotope Indium-111. |
trade name LymphoScan) is a mouse monoclonal | antibody labelled with the radioactive isotope technet |
t was the Fab' fragment of a mouse monoclonal | antibody labelled with the radioisotope indium-111 for |
, CD93 deficient mice failed to maintain high | antibody level upon immunization and present a lower a |
As with all serological tests, the rise in | antibody levels needed to perform the diagnosis takes |
rade name Hybri-ceaker) is a mouse monoclonal | antibody linked to pentetate which acts as a chelating |
This was first done in 1989, with a mouse | antibody made by tobacco plants . |
As the "footprint" that an | antibody makes on its binding target is roughly a circ |
ly to several types of protein targeting: the | antibody may remain in the cytoplasm, or it may have a |
ctively type DQ2 bearing individuals, however | antibody may detect DQB1*0303. |
Taken together, the data indicated that each | antibody may elicit different responses on EGFR downst |
Alternatively the secondary | antibody may be covalently linked to a fluorophore (FI |
the tumor cell surface, anti-HER2 monoclonal | antibody MGAH22 may induce an antibody-dependent cell- |
The most common protein microarray is the | antibody microarray, where antibodies are spotted onto |
limited to DNA analysis; protein microarrays, | antibody microarray, chemical compound microarray can |
n repeat proteins) are genetically engineered | antibody mimetic proteins typically exhibiting highly |
ted to antibodies, which makes them a type of | antibody mimetic. |
Affitins are | antibody mimetics and are being developed as an altern |
While antibodies and most other | antibody mimetics can only be directed at macromolecul |
On living B cells, anti-immunoglobulin | antibody mimicking exogenous antigen causes CD19 to bi |
A single | antibody molecule has two antigen receptors, wherefore |
It is the binding of a specific part of the | antibody molecule to the C1 component that initiates t |
portraying the human | antibody molecule, a sculpture for Nobel laureate Rode |
Janda has also worked creating peptide and | antibody molecules for the treatment of cancer. |
It is triggered by antigen-bound | antibody molecules. |
Anti-mesothelin monoclonal | antibody MORAb-009 binds to mesothelin (a protein that |
Anti-mesothelin monoclonal | antibody MORAb-009 is a monoclonal antibody being stud |
Chimeric | antibody names contain a -xi- stem. |
Figure 2. A specific | antibody of choice is used to enrich protein of intere |
d not the a2iib3 integrin activation specific | antibody of the same name |
se enzymes whose active site is blocked by an | antibody or chemical that only dislodges once the reac |
ns that have selective affinity to a specific | antibody or DNA molecule. |
sed to detect the presence of either specific | antibody or specific antigen in a patient's serum. |
meric proteins are usually made of a modified | antibody or antibody fragment, attached to a fragment |
The bait protein is identified using an | antibody or a recombinant tag which allows it to be ex |
against infections, which can operate without | antibody participation. |
Other | antibody parts (such as Fc regions) and antibody mimet |
CP-675,206) is a fully human IgG2 monoclonal | antibody produced by Pfizer. |
こんにちは ゲスト さん
ログイン |
Weblio会員(無料)になると 検索履歴を保存できる! 語彙力診断の実施回数増加! |
こんにちは ゲスト さん
ログイン |
Weblio会員(無料)になると 検索履歴を保存できる! 語彙力診断の実施回数増加! |